Fed up of endless wait?
Look for clinic with Prime
Dr. Anas  Younes Internal Medicine in New York

Dr. Anas Younes

Claim this profile

Class of 1983, Residency in Internal Medicine, Fellowship in Medical Oncology

Internal Medicine
43 Years Experience Overall

Medical Registration Verified

Dr. Anas Younes is a Internal Medicine,General Physician and Oncologist in Lenox Hill, New York and has an experience of 43 years in these fields. Dr. Anas Younes practices at Memorial Sloan Kettering Cancer Center New York - Main Hospital in Lenox Hill, New York. He completed Fellowship from Memorial Sloan Kettering in 1992,Residency from SUNY HSC in 1989 and Residency from University of Toledo College of Medicine and Life Sciences in 1985. He is a member of Member of the Scientific Advisory Board of the Lymphoma Research Foundation,Past member of the Scientific Advisory Board of the Lymphoma Research Foundation,Past Member of the National Cancer Institute Lymphoma Steering Committee,Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Lymphoma, American College of Radiology and Principal Investigator of a SCOR grant supported by the Leukemia & Lymphoma Society. Some of the services provided by the doctor are: COPD (Chronic Obstructive Pulmonary Disease),Athlete's Foot,Treatment Of Erectile Dysfunction,identification of biomarkers for treatment and Influenza (Flu) etc.

This platform is intended for use by patients with commercial insurance or who are paying for healthcare services directly (self-pay). It is not available for patients covered by Medicare, Medicaid, or other federal healthcare programs.

329 Surgeries & Treatments

identification of biomarkers for treatment

identification of biomarkers for treatment

development of targeted therapies for lymphoma

development of targeted therapies for lymphoma

Phase I trial of CUDC-907

Phase I trial of CUDC-907

Research on epigenetic therapies

Research on epigenetic therapies

Immune checkpoint inhibitor (nivolumab)

Immune checkpoint inhibitor (nivolumab)

Targeted drug for Hodgkin lymphoma (brentuximab vedotin)

Targeted drug for Hodgkin lymphoma (brentuximab vedotin)

Nivolumab

Nivolumab

Brentuximab vedotin

Brentuximab vedotin

Targeted therapies for lymphoma

Targeted therapies for lymphoma

clinical trials for lymphoma

clinical trials for lymphoma

Pick a time slot

Clinic Appointment
Memorial Sloan Kettering Cancer Center New York - Main Hospital
0
Lenox Hill